Literature DB >> 16174892

A 70-year-old woman with poor grade subarachnoid hemorrhage complicated by carotid stenosis, cerebral vasospasm, and cerebral rebleed.

Nazli Janjua1, Adnan I Qureshi, Adnan Qureshi, Jawad F Kirmani, Giuseppe Lanzino, Gene Sung, Jose I Suarez, Ali Ebrahimi, Afshin A Divani, Afshin Divani.   

Abstract

INTRODUCTION: Subarachnoid hemorrhage is one of the most common entities encountered in neurocritical care units. Knowledge of disease sequelae and their management is paramount for all neurointensivists.
MATERIALS AND METHODS: This study relates the case of a 70-year-old woman with poor grade subarachnoid hemorrhage who underwent endovascular detachable coil embolization of a right internal carotid artery aneurysm. Her hospital course was subsequently complicated by symptomatic carotid stenosis and cerebral vasospasm requiring intervention. DISCUSSION: The discussants present their views regarding five main questions pertaining to management of the patient regarding the choice of endovascular versus surgical aneurysm occlusion, stent-supported angioplasty in a patient with a recent subarachnoid hemorrhage, and treatment options for vasospasm.

Entities:  

Mesh:

Year:  2005        PMID: 16174892     DOI: 10.1385/ncc:3:2:183

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  25 in total

Review 1.  Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II--Clinical aspects and recommendations.

Authors:  A I Qureshi; A R Luft; M Sharma; L R Guterman; L N Hopkins
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

2.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

3.  Factors associated with withdrawal of mechanical ventilation in a neurology/neurosurgery intensive care unit.

Authors:  M N Diringer; D F Edwards; V Aiyagari; H Hollingsworth
Journal:  Crit Care Med       Date:  2001-09       Impact factor: 7.598

4.  Intentional partial coil occlusion followed by delayed clip application to wide-necked middle cerebral artery aneurysms in patients presenting with severe vasospasm. Report of two cases.

Authors:  Jonathan L Brisman; Chan Roonprapunt; Joon K Song; Yasunari Niimi; Avi Setton; Alejandro Berenstein; Eugene S Flamm
Journal:  J Neurosurg       Date:  2004-07       Impact factor: 5.115

5.  Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm.

Authors:  Neeraj Badjatia; Mehmet A Topcuoglu; Johnny C Pryor; James D Rabinov; Christopher S Ogilvy; Bob S Carter; Guy A Rordorf
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

Review 6.  Outcome following intracerebral hemorrhage and subarachnoid hemorrhage.

Authors:  Ricardo A Hanel; Andrew R Xavier; Yousef Mohammad; Jawad F Kirmani; Abutaher M Yahia; Adnan I Qureshi
Journal:  Neurol Res       Date:  2002       Impact factor: 2.448

7.  Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.

Authors:  I A Awad; L P Carter; R F Spetzler; M Medina; F C Williams
Journal:  Stroke       Date:  1987 Mar-Apr       Impact factor: 7.914

8.  Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage.

Authors:  J van Gijn; K J van Dongen; M Vermeulen; A Hijdra
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

9.  Validity of prediction of the site of ruptured intracranial aneurysms with CT.

Authors:  M van der Jagt; D Hasan; H W Bijvoet; H Pieterman; D W Dippel; F H Vermeij; C J Avezaat
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

10.  Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm.

Authors:  W McAuliffe; M Townsend; J M Eskridge; D W Newell; M S Grady; H R Winn
Journal:  J Neurosurg       Date:  1995-09       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.